Here's a Cancer-Killing Stock to Buy for 2021
In our bodies we have cancer-killer cells called "natural killer" cells, or NK cells. These cells are part of our innate immune system. When an NK cell comes across a malign cancer cell in the human body, the NK cell attacks it and destroys it. Scientists believe that this natural cancer-killer might unlock secrets to help us fight cancer.
Small, cutting-edge biotech companies want to harness these NK cells and grow them into effective cancer therapies. And in 2020 the market got rather excited about this scientific field. Shares of Fate Therapeutics (NASDAQ: FATE) ran up 374% in 2020, while NantKwest (NASDAQ:NK) jumped 262%. Here's why you should buy one stock, but probably not the other.
Source Fool.com
